Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Cyanophyta Aphanizomenon Flos-aquae (Stemregen), and Adipose Stroma Vascular Fraction (SVF) Either Individual or in Combination in Patient With Heart Failure

NCT04515537 is registered in ClinicalTrials.gov with Sociedad Española de Medicina Regenerativa y Terapia Celular as lead sponsor.

NCT NCT04515537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04515537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Cyanophyta Aphanizomenon Flos-aquae (Stemregen), and Adipose Stroma Vascular Fraction (SVF) Either Individual or in Combination in Patient With Heart Failure
Lead sponsor
Sociedad Española de Medicina Regenerativa y Terapia Celular
Phase
Observational
Overall status
Unknown status
Start date
May 20, 2021
Completion date
September 30, 2023
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure chronic